Correlation Between Apogee Therapeutics and CCC Intelligent

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Apogee Therapeutics and CCC Intelligent at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Apogee Therapeutics and CCC Intelligent into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Apogee Therapeutics Common and CCC Intelligent Solutions, you can compare the effects of market volatilities on Apogee Therapeutics and CCC Intelligent and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Apogee Therapeutics with a short position of CCC Intelligent. Check out your portfolio center. Please also check ongoing floating volatility patterns of Apogee Therapeutics and CCC Intelligent.

Diversification Opportunities for Apogee Therapeutics and CCC Intelligent

-0.79
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Apogee and CCC is -0.79. Overlapping area represents the amount of risk that can be diversified away by holding Apogee Therapeutics Common and CCC Intelligent Solutions in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CCC Intelligent Solutions and Apogee Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Apogee Therapeutics Common are associated (or correlated) with CCC Intelligent. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CCC Intelligent Solutions has no effect on the direction of Apogee Therapeutics i.e., Apogee Therapeutics and CCC Intelligent go up and down completely randomly.

Pair Corralation between Apogee Therapeutics and CCC Intelligent

Given the investment horizon of 90 days Apogee Therapeutics Common is expected to generate 1.26 times more return on investment than CCC Intelligent. However, Apogee Therapeutics is 1.26 times more volatile than CCC Intelligent Solutions. It trades about 0.24 of its potential returns per unit of risk. CCC Intelligent Solutions is currently generating about -0.16 per unit of risk. If you would invest  5,321  in Apogee Therapeutics Common on October 9, 2025 and sell it today you would earn a total of  2,504  from holding Apogee Therapeutics Common or generate 47.06% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy27.87%
ValuesDaily Returns

Apogee Therapeutics Common  vs.  CCC Intelligent Solutions

 Performance 
       Timeline  
Apogee Therapeutics 

Risk-Adjusted Performance

Solid

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Apogee Therapeutics Common are ranked lower than 18 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak technical and fundamental indicators, Apogee Therapeutics exhibited solid returns over the last few months and may actually be approaching a breakup point.
CCC Intelligent Solutions 

Risk-Adjusted Performance

Weakest

 
Weak
 
Strong
Over the last 90 days CCC Intelligent Solutions has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's fundamental indicators remain comparatively stable which may send shares a bit higher in February 2026. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Apogee Therapeutics and CCC Intelligent Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Apogee Therapeutics and CCC Intelligent

The main advantage of trading using opposite Apogee Therapeutics and CCC Intelligent positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Apogee Therapeutics position performs unexpectedly, CCC Intelligent can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CCC Intelligent will offset losses from the drop in CCC Intelligent's long position.
The idea behind Apogee Therapeutics Common and CCC Intelligent Solutions pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.

Other Complementary Tools

Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
CEOs Directory
Screen CEOs from public companies around the world
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.